Finally, we analyzed mRNA levels of CHMP2B with real-time quantitative PCR and found no differences between Control- and FTD-hESCs (Supplementary Fig. 2A), suggesting that the editing process or presence of the intron 5 mutation did not alter CHMP2B expression levels. This evidence concerns the gene CHMP2B and frontotemporal dementia.